Bei Akademie registrieren

Thema: US92764N1028

coin-1549061_1920.jpg - Foto: THN
coin-1549061_1920.jpg - Foto: THN
VIR, US92764N1028

Vir Biotechnology stock: Gilead deal brings up to USD 135 ...

Vir Biotechnology entered a three-candidate Gilead deal on October 14, 2026. For Vir Biotechnology stock, results are due November 4, 2026.

ad-hoc-news.de, 24.10.26 01:40 Uhr
business-21681_1920.jpg - Foto: THN
business-21681_1920.jpg - Foto: THN
VIR, US92764N1028

Vir Biotechnology enters Gilead deal: what it means for ...

Gilead deal offers Vir Biotechnology stock up to USD 135 million upfront. Three candidates are due for a November 8, 2026 data event.

ad-hoc-news.de, 16.10.26 04:44 Uhr
money-6990721_1920.jpg - Foto: THN
money-6990721_1920.jpg - Foto: THN
VIR, US92764N1028

Vir Biotechnology stock gained 5.46 percent before SOLSTICE ...

Vir Biotechnology will present Week 96 SOLSTICE results on November 8, 2026. Eight analysts support a Moderate Buy consensus, with targets from USD 18.00 to USD 30.00.

ad-hoc-news.de, 07.10.26 03:58 Uhr
gamestop-6286877_1920.jpg - Foto: THN
gamestop-6286877_1920.jpg - Foto: THN
VIR, US92764N1028

Raymond James reiterates USD 19.00 target for Vir Biotechnology ...

Vir will present hepatitis delta data on November 8, 2026. Eight analysts give Vir Biotechnology stock a USD 21.57 average target in consensus.

ad-hoc-news.de, 06.10.26 05:31 Uhr
wall-street-621097_1920.jpg - Foto: THN
wall-street-621097_1920.jpg - Foto: THN
VIR, US92764N1028

Raymond James reiterates USD 19.00 target for Vir Biotechnology ...

Revenue hit USD 238.95 million in the second quarter, up 19,582.50 percent year over year. Vir Biotechnology stock has USD 1.9 billion market cap.

ad-hoc-news.de, 01.10.26 12:00 Uhr
Börsen-Editorial-Szene im Trading-Saal illustriert den Aktienkurs von Virbac S.A., FR0000031577, mit passenden Pharma-Branchencharts - Foto: THN
Börsen-Editorial-Szene im Trading-Saal illustriert den Aktienkurs von Virbac S.A., FR0000031577, mit passenden Pharma-Branchencharts - Foto: THN
VIR, US92764N1028

Vir Biotechnology stock gains on conference catalyst

Vir Biotechnology stock gained after a new 52-week high and a conference appearance. MarketBeat also cites a close of USD 11.63 on September 1 2026 with market cap at USD ...

ad-hoc-news.de, 03.09.26 13:22 Uhr
iphone-4004683_1920.jpg - Foto: THN
iphone-4004683_1920.jpg - Foto: THN
VIR, US92764N1028

Vir Biotechnology stock gains on new 52-week high and conference ...

Vir Biotechnology stock has climbed to a fresh 52-week high with investors watching the upcoming Morgan Stanley healthcare conference and recent analyst price targets as key ...

ad-hoc-news.de, 03.09.26 08:05 Uhr
usa-3004860_1920.jpg - Foto: THN
usa-3004860_1920.jpg - Foto: THN
VIR, US92764N1028

Vir Biotechnology stock gains on conference participation ...

Vir Biotechnology stock has climbed strongly in recent weeks with investors now watching its upcoming appearance at a major healthcare conference and the stock’s move to ...

ad-hoc-news.de, 02.09.26 06:33 Uhr
wall-street-621097_1920.jpg - Foto: THN
wall-street-621097_1920.jpg - Foto: THN
VIR, US92764N1028

Vir Biotechnology stock (US92764N1028): focus shifts from ...

Vir Biotechnology is repositioning itself after the COVID boom with investors watching the RSV and influenza portfolio oncology ambitions and the company’s sizeable cash ...

ad-hoc-news.de, 09.06.26 22:21 Uhr